title: Assessment of ocular pain following ranibizumab intravitreal injection.
authors.affiliation: Department of Ophthalmology, Centre Hospitalier de Cergy Pontoise, Cergy, France.
authors.forename: Nathalie
authors.initials: N
authors.lastname: Massamba
authors.forename: Maud
authors.initials: M
authors.lastname: Elluard
authors.forename: Wassila
authors.initials: W
authors.lastname: Agoune
authors.forename: Vincent
authors.initials: V
authors.lastname: Guyader
authors.forename: April
authors.initials: A
authors.lastname: Ingram
authors.forename: Bernard
authors.initials: B
authors.lastname: Pasquier
authors.forename: Juliette
authors.initials: J
authors.lastname: Knoeri
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D058447:Eye Pain / Q000175:diagnosis*; D005260:Female; D006801:Humans; D058449:Intravitreal Injections; D008269:Macular Edema / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010147:Pain Measurement / Q000706:statistics & numerical data*; D011446:Prospective Studies; D000069579:Ranibizumab / Q000008:administration & dosage*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D057135:Wet Macular Degeneration / Q000188:drug therapy
chemical_list: D020533:Angiogenesis Inhibitors; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000069579:Ranibizumab